SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-248492
Filing Date
2018-08-14
Accepted
2018-08-14 16:24:08
Documents
79
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d486131d10q.htm 10-Q 768835
2 EX-10.3 d486131dex103.htm EX-10.3 34205
3 EX-10.4 d486131dex104.htm EX-10.4 33894
4 EX-31.1 d486131dex311.htm EX-31.1 11005
5 EX-31.2 d486131dex312.htm EX-31.2 11217
6 EX-32.1 d486131dex321.htm EX-32.1 4308
7 EX-32.2 d486131dex322.htm EX-32.2 4794
  Complete submission text file 0001193125-18-248492.txt   4350178

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT alt-20180630.xml EX-101.INS 603156
9 XBRL TAXONOMY EXTENSION SCHEMA alt-20180630.xsd EX-101.SCH 52073
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE alt-20180630_cal.xml EX-101.CAL 83433
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE alt-20180630_def.xml EX-101.DEF 248438
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE alt-20180630_lab.xml EX-101.LAB 462803
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alt-20180630_pre.xml EX-101.PRE 340117
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 181017934
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1